Loading stock data…
Loading stock data…
US$1.69
Get one email when PULM crosses your level. Checked every 15 minutes during market hours.
▲ +0.08 (4.97%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
56.5
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.05
Bearish momentumMACD below its signal line (0.07).
50-day average
1.47
Price aboveShort-term trend reference.
200-day average
2.65
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Pulmatrix Inc. is a biotechnology company focused on the discovery and development of innovative inhaled therapies to address significant unmet needs in respiratory diseases. The company's primary function is to leverage its proprietary iSPERSE inhaled dry powder technology to create therapies that improve treatment delivery and efficacy. Pulmatrix aims to transform the treatment landscape for diseases such as chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fungal infections.…
www.pulmatrix.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-03-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-02-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-01-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2024-12-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-25 | -0.14 | -0.16 | ✗ Miss |
| 2026-01-07 | 1.94 | 2.13 | ✓ Beat |
| 2025-10-14 | 0.45 | 0.51 | ✓ Beat |
| 2024-03-27 | — | -0.57 | — |
| 2023-11-09 | -1.05 | -1.03 | ✓ Beat |
| 2023-08-10 | -1.23 | -1.04 | ✓ Beat |
| 2023-05-11 | — | -1.22 | — |
Companies in the same industry, via Finnhub